Open access peer-reviewed chapter

Bicuspid Aortic Valve

By Ayşe Inci Yıldırım and Aysu Türkmen Karaağaç

Submitted: November 3rd 2017Reviewed: March 20th 2018Published: October 3rd 2018

DOI: 10.5772/intechopen.76643

Downloaded: 171


Bicuspid aortic valve (BAV) is one of the most common congenital diseases, affecting 1–2% of the general population. Although most of them are sporadic, some familial cases have also been detected. BAV is a complex developmental and progressive pathology, which may present with various clinical findings from newborn to adulthood. It may be suspected during cardiac auscultation or may be diagnosed by echocardiography incidentally. Some BAV cases may remain symptomless for years, with findings like valvular stenosis, insufficiency, or dilatation in the ascending aorta, whereas some others may present with early severe aortic valve dysfunction, premature congestive heart failure, and aortic aneurysms even in the newborn period. Such heterogeneous presentations of BAV phenotypes may be associated with congenital, genetic, and/or connective tissue abnormalities. The natural course of BAV is nonpredictable, it may lead to severe morbidity and mortality.


  • aortopathy
  • aortic regurgitation
  • aortic stenosis
  • aortic dilatation
  • aortic dissection

1. Introduction

Bicuspid aortic valve (BAV) is one of the most common congenital heart diseases. It is phenotypically variable and genetically heterogeneous. The prevalence of the disease has been determined according to the results of echocardiographic screening and necropsy studies. Some patients with isolated BAV may remain asymptomatic throughout their lives, so they may be diagnosed accidentally in echocardiographic screening. Although it is difficult to define the real incidence of BAV, it is accepted to have a prevalence of 0.5–2% in the general population, with a higher prevalence in males than females: M/F = 3/1 [1, 2]. The clinical presentation of BAV is highly variable. Its major manifestations are aortopathy, valvular dysfunctions, endocarditis, and dissection. In the patients presenting with valvular dysfunction earlier in life, aortic regurgitation (AR) is more common, whereas aortic stenosis (AS) is more prevalent later in life, after the fourth decade. Valve phenotypes, genetic, and hemodynamic factors have been proposed as underlying mechanisms of aortopathy. Ascending aortic aneurysm is generally due to aortopathy and hemodynamics; however, the aortic root aneurysm is considered to be a consequence of aortopathy rather than hemodynamics, especially in younger patients. The asymptomatic BAV patients with normal valvular function require surgical treatment less frequently than those with valvular dysfunction and aortopathy during their lives.

Moreover, BAV may be associated with several genetic disorders with cardiovascular manifestations such as hypoplastic left-heart syndrome, congenital left-sided obstructive lesions (coarctation of aorta, Shone complex), ventricular septal defect, and syndromic conditions (Turner, Loeys Dietz). This chapter enrolls only the isolated bicuspid aortic valves.

2. Genetic and inheritance

2.1. Associated with genetic syndrome

Although most of the BAV patients are sporadic or familial, some may have the symptoms knowngenetic syndromes as Trisomy 18, Williams syndrome, and Turner syndrome. The highest penetrance of BAV (>30%) occurs in woman with Turner syndrome caused by partial or complete absence of one X chromosome [3]. In the general population, BAV is more prevalent in men than women, suggesting that the loss of genes on the X chromosome may predispose to BAV phenotype [3, 4].

2.2. Familial inheritance and genetic etiologies

The heritability of BAV is now well established; however, the genes linked to the defect remain largely unknown. Autosomal dominant, X-linked, and familial modes of inheritance have been reported. BAV heritage revealed a high incidence of familial clustering. The study performed in the Canadian population revealed that 11 of 30 families (36%) had at least 1 additional member with BAV, and the recurrence rate in first-degree relatives was 9% [5]. Another study reported that 100 out of 448 subjects in a Mediterranean population had BAVs, 348 of which were first-degree relatives. In this study, the BAV recurrence rate in the first-degree relatives was 4.6%. This value was clearly lower than that in the Canadian population. The populations or geographic areas may affect the prevalence of BAVs [6].

Epidemiologic studies have demonstrated that BAV is heritable and follows an autosomal dominant mode of transmission with reduced penetrance and variable expressivity [7, 8]. Through the linkage analysis of BAV pedigrees, investigators have found multiple genetic loci and chromosomes associated with BAV disease [7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. The most significantly associated genes and the chromosomes they are located on are shown in Table 1. However, some of these gene mutations have been found to be related with aortopathies. Several mouse studies have showed that the NOTCH1 gene mutation plays an important role in the development of ascending aorta aneurysm and BAV [8, 9, 16]. Although the FBN1 gene mutation frequently accompanies Marfan syndrome, its association with BAV and ascending aorta dilatation has been shown in a recent study [17]. The pathologic hallmark of aortic aneurysm is medial degeneration. Disruption of the smooth muscle cells’ (SMC) contractility due to mutations may lead to aortic aneurysm. Mutations in the MYH11 and ACTA2 genes are associated with the familial thoracic aortic aneurysms [18].

Candidate genesChromosomal regions
TGFBR2 (Transforming growth factor, beta receptor II)3p24.1
NKX2.5 (NK2 Homeobox 5)5q35.1
NOTCH1 (Translocation-associated notch protein TAN-1)9q34.3
ACTA2 (Actin, alpha 2)10q23.31
MYH6 (Myosin heavy chain 6)14q11.2
MYH7 (Myosin heavy chain 7, cardiac muscle, beta)14q11.2
FBN1 (Fibrillin 1)15q21.1
ENG (Endoglin)9q34.11
AXIN1 (Axin 1)16p13.3
KCNJ2 (Potassium channel, inwardly rectifying subfamily J, member 2)17q24.3
GATA5 (GATA binding protein 5)20q13.33
PDIA2 (Protein disulfide isomerase family A, member 2)16p13.3
TGFBR 1 (Transforming growth factor, beta receptor I)9q22.33

Table 1.

Genes with association with bicuspid aortic valve.

Consequently, BAV and aortopathy are complex multifactorial and multigenetic pathologies. Genetic, epigenetic, and environmental modifiers may be responsible for the variable penetrance and phenotypic expression [4].

3. Aortic root

3.1. Embryology of aortic root

Cardiac and valve morphogenesis occur in early fetal life. Actually the abnormal valvulogenesis of BAV has not been clearly understood. Earlier theories proposed that abnormal blood flow across the developing valves would result in the failure of cusp separation. Current theories suggest that cell migration, signaling pathway, and genetic susceptibility are the main factors in the development of BAV disease.

The embryonic heart and aorta are developed from three precursor cells: proepicardial cells, cardiogenic mesodermal cells (contribute to first and second heart fields [SHfs]), and neural crest cells. Second heart field (SHF) and the cardiac neural crest (CNC) contribute to the development of aortic root, ascending aorta, and aortic arc. Paraxial mesoderm plays role in the development of descending aorta [19, 20]. First heart field (FHF) forms the early embryonic heart tube that contributes to the left ventricle and a portion of the right ventricle and atria. SHF contributes to the myocardium of the outflow tract to form the truncus arteriosus. Mesenchymal cells originating from the migrating cardiac neural crest cells reach the outflow tract cushions and contribute to the formation of the aortic and pulmonary valves together with the endocardially derived mesenchymal cells. Abnormal migration of neural crest cells has been postulated as a common pathway that results in BAV and aortopathy [21, 22, 23, 24].

Several proteins are used to determine the positional and functional relationship of various cellular populations during embryogenesis. Conical Wnt, non-conical Wnt, TGF-β, fibroblast growth factor, bone morphogenetic protein, and Notch are some important proteins in the development of aortic valve and aorta. Errors of this pathway may result in various outflow tract structural abnormalities including BAV disease [11, 16, 19, 23].

3.2. Histopathology of the aorta

The normal aortic valve involves three layers. The first layer is the inner intimal layer, which consists of endothelial cells. The second layer is the thicker medial layer formed of smooth muscle cells (SMCs) and elastin. The elastin is arranged in fenestrated sheets (lamellae) between which collagen fibers, thin layers of proteoglycan-rich extra-cellular matrix (ECM), and SMCs are located. Thin elastic fibers embed lamellae into a three-dimensional network and connect them with SMCs. The third layer is the strong adventitial layer with collagen fibers wrapping the aorta [25, 26]. The relatively high collagen content of the adventitia prevents vascular rupture at extremely high pressures [27]. SMC and ECM play an important role both in the normal tissue development and in the main mechanical function of the aortic media [2, 28, 29]. SMCs are the major cell types of the aortic wall that synthesize and organize the ECM with the elastic fiber network in the arterial wall [25, 26, 30]. SCMs also provide lamellar organization, depending on the diameter and stress applied upon the vessels during embryogenesis. ECM, mainly composed of elastin and collagen, is important for the aortic strength and flexibility to withstand the arterial blood pressure [26]. The number of lamella is greater in larger vessels facing greater wall tension and it seems to remain stable after birth. In the normal aorta, SMCs have a little active role in managing wall tension; microfibrillar structure is the major passive contributor [26, 30]. As the vessel wall matures, SMCs condense down around the endothelial tube to form the circumferential layers, which will finally define the elastic lamellae of the mature vessel [30].

3.3. Pathogenesis of aortopathy

Aortopathy is very complex pathology, in which both cellular and extracellular mechanisms are involved. Possible mechanisms for aortopathy in patients with BAV include medial degeneration (elastic fiber fragmentation and smooth muscle cell apoptosis), fibrilin-1 deficiency, increased metalloproteinase (MMP), and decreased MMP tissue inhibitor expression.

Medial degeneration: Failure of the balance between the synthesis and degradation of ECMs in the aortic wall leads to aortic aneurysm. Especially elastin is the major fibrillar component in the arterial wall, so its destruction directly leads to the expansion of aorta. Moreover, some intrinsic medial degenerative differences have been identified between TAV and BAV patients. While degeneration in TAVs has been attributed to inflammation and accelerated aging, it has been attributed to the maturation defect in BAVs. Several BAV studies have revealed noninflammatory loss of vascular SMCs, less-differentiated vascular SMC, low laminin A/C, and progerin expression as the other causes of medial degeneration [27, 30, 31]. The total thickness of the aortic media is the same for BAV and TAV aortas, but the distance between the elastic lamellae is greater and the lamellae themselves are thinner and more fragmented in BAV patients [30, 32]. It was suggested that matrix disruption and SMC apoptosis were earlier in BAVs with stenosis than TAVs with respect to the dilatation of aorta [33]. The patients with ascending aorta dilatation with BAV showed lesser cystic medial necrosis (focal loss of vacsular smooth muscle cell (VSMC) nuclei in the media) than those with TAV [30]. Nondilated BAV aortas may have higher rates of vascular SMC apoptosis, particularly at the convexity, where wall stress is expectedly higher. Stress-dependent BAV matrix changes may trigger early apoptosis [33].

Deficiency of fibrilin-1: Maturation defect is maintained in the dilated aortic wall in BAV patients. Fibrillin-1, which stabilizes the vascular wall, is secreted by the SMC. It is low in BAV patients because of the immaturity of SMC [21]. Deficiency of fibrillin-1 results in vascular SMC detachment, matrix disruption, and apoptosis, which ultimately result in a fragile aorta, less suited to deal with stress associated with valvular dysfunction. Decreased levels of fibrillin-1 may also lead to tinning and weakening of the aortic wall. Some studies have showed that aortic tissues in BAVs have significantly less fibrillin-1 than TAV aortas [34, 35].

Increased activity of MMPs: To date, most studies have focused on MMP-2 and MMP-9, which belong to a subclass of MMP. An increase in MMPs, enzymes that process or degrade the extracellular matrix, may lead to the weakening of the aortic wall and may be associated with the development of aortic aneurysms. In particular, MMP-2 and MMP-9, secreted from macrophages, which have infiltrated the inflammatory site, are known as powerful proteinases that degrade elastin fiber. BAV patients have dilated aortas with a higher content of MMP and a lower level of tissue inhibitor of MMP compared to TAV patients, indicating an increased collagen turnover. MMP-9 has been closely associated with the formation of abdominal aortic aneurysms [31, 36]. MMP-2 has been identified as a key molecular modulator and a circulation biomarker of aortic dilation in patients with BAV [36]. Several markers as c-Kit (a marker for differentiated vascular SMCs), pc-Kit (phosphorylated state of c-Kit, triggered by the presence of MMP9), HIF1a (influencing hypoxia-inducible-factor-1alpha), and endothelial nitric oxide synthase might play an important role in the pathogenesis of the aortopathy [31]. Increased collagen turnover and decreased collagen cross-linking may be another factor in the formation of aneurysms in BAV cases [37].

4. Phenotypic presentation of aortic valve and root

4.1. Morphology of bicuspid aortic valve

Normal aortic valve is tricuspid, meaning it possesses three leaflets (or cusps: the left coronary, the right coronary, and non-coronary cusps, named after their relationship to the coronary arteries). However, BAV is formed of two functional leaflets. There are two types of BAV. The typical one is the most frequent and is formed of two leaflets of unequal size with complete or incomplete fusion of two cusps. Adjacent cusps fuse into a single cusp, that is generally bigger than its counterpart cusp, but these fused cusps are smaller than two normal cusps combined. In such cases, there may be one or two raphe. The term “raphe” refers to the fused area of two underdeveloped cusps turning into malformed commissure between both cusps [28, 29]. The second and less commonly encountered type of BAV is “true BAVs,” which have leaflets equal in size with no raphe [28]. Morphology of the aortic valve is defined according to spatial position of cusps, fusion types, and the number of raphe. The valve morphologies, raphe number, and fusion types are shown in Table 2. The fusion positions between the right and left coronary cusps (RL BAV), right and non-coronary cusps (RN BAV), and true BAVs are shown in Figure 1. The most prevalent aortic valve morphologies are RL BAV phenotypes and second, RN BAV phenotypes, and the least common are LN BAV phenotypes [28, 29, 38, 39].

Morphology of aortic valveType 1Type 2Type 3
Raphe present
(Complete or incomplete fusion)
Valve opening
Right–left coronary cusps fusion
Right-non-coronary cusps fusion
Left-non-coronary cusps fusion
Raphe number*1 raphe2 raphe
Raphe absent
Valve opening

Table 2.

The bicuspid aortic valve morphologies, fusion types, and raphe number.

Type 0: no raphe

Figure 1.

Echocardiographic views of commissural fusion patterns of BAVs and true BAVs. In the first view: Right-left coronary cusp fusion a) closed b) opened position; in the second view: Right non coronary cusp fusion a) closed b) opened position; in the third view: true BAV anterior-posterior valve position a) closed b) opened position; in the fourth view: True BAV right-left position a) closed b) opened position. RCC: right coronary cusp, LCC: left coronary cusp, NCC: non coronary cusp, ANT: anterior, POST: posterior.

4.2. Aortic phenotype

The aorta is anatomically composed of ascending aorta, aortic arch, thoracic aorta, and abdominal aorta. The aortic root contains aortic sinuses, aortic valve, and coronary ostia. The tubular portion of the ascending aorta begins at a point distal to the aortic root (sinotubular junction) and ends at the origin of the innominate artery. The aortic arch includes the origins of innominate artery, the left common carotid artery, and the left subclavian artery [40]. Figure 2 shows the echocardiographic images and the measurements of aortic root, tubular portion of the ascending aorta, and aortic arc. There are computerized tomography images of various aortic phenotypes in Figure 3.

Figure 2.

Echocardiografic images revealing the measurements of a) aortic root in the long axis view at the annular, sinus valsalva, sinotubular junction and ascending aorta levels b) aortic arc at the transverse arc, isthmus and descending aorta levels c) sinus valsalva dilatation in long axis view d) ascending aorta dilatation in which aortic root was spared in long axis view e) aortic root and ascending aorta dilatation in long axis view.

Several classifications have been made according to the structure, diameter of aorta, and the extent of aortic dilatation. BAV aortopathies generally present with ascending aorta dilatation or root dilatation or both. The types of aortopathies are summarized in Table 3. The most common types of aortic dilatation which are seen are the ascending aorta and varying degrees of aortic root. This type was associated with an older age at diagnosis (>50 years), valvular stenosis, and the RL BAV fusion pattern [29, 40, 41]. Isolated dilatation of the aortic root is a rare type and associated with younger age at diagnosis (<40 years), male sex, aortic regurgitation, and aortopathy. This type was considered most likely to be related with a genetic cause [29, 40, 41, 42].

Shafer et al. [28]Type N (normal root)
Ascending < sinuses >STJ
Type A (ascending dilatation)
Ascending > sinuses >STJ
Type E (effaced roots)
Sinuses < STJ
Fazel et al. [43]Cluster I
Aortic root alone
Cluster II
Tubular ascending aorta alone
Cluster III
Tubular portion and transverse arch
Cluster IV
Aortic root and tubular portion with tapering across the transverse arc
Verma et al. [41]Type 1
Dilatation of tubular ascending aorta primarily along convexity of aorta, with mild-to-moderate root dilatation
Type 2
Arch dilatation with involvement of tubular ascending aorta, with relative sparing of root
Type 3
Isolated aortic-root involvement with normal tubular ascending aorta and arch dimensions

Table 3.

Aortic dilatation pattern.

STJ: sinotubular junction

4.3. Aortic dilatation

Aortic dimensions are generally measured at the levels of annulus, sinus Valsalva, sinotubular junction (STJ), ascending aorta, aortic arch, descending aorta, and abdominal aorta, from inner edge to inner edge, at the end of diastole in the echocardiographic evaluation. Figure 3 shows computerized tomography images of aortic root and ascending aorta. Because the aorta increases in diameter with somatic growth in children, the aortic diameter is typically corrected, mostly for body surface area (BSA), age, and gender. It is important to evaluate children under the age of 18 according to the z scores of these measurements. Aorta is accepted to have dilatation if the aortic z score is >2, aortic/expected aortic diameter is >1.15, or it is 2 SD above the mean expected diameter. Aortic dilation was defined as mild (z score > 2 and ≤ 4), moderate (z score > 4 and ≤ 6), or severe/aneurysm (z score > 6 or > 6 SD above the mean for BSA) [43]. In adults, aortic dilatation is present if the diameter of sinus Valsalva is >35 mm, ascending aorta diameter is >34–38 mm, and an aneurysm is present if the aortic/expected diameter is >1.4 or ascending aorta is >45 mm [44, 45, 46, 47].

Figure 3.

Three dimensional computerized tomography images showing a) ascending aorta dilatation b) sinus valsalva and ascending aorta dilatation extended to arcus aorta c) aortic root and ascending aorta dilatation.

Aortic dilatation may begin early in life and progress with age. It is three times more common in BAV patients than in TAVs [48]. In total, 40% of patients in referral centers were reported to have BAV-associated aortopathy [49]. BAV patients have significantly larger proximal aorta than those with TAV, even in the absence of significant valvular hemodynamic disturbance. Children with BAV have larger sinus Valsalva and ascending aorta, which increase in size at a higher rate than TAVs [48, 50]. Studies showed that aortic aneurysm also was more common in BAV than in TAV patients. The most common type of dilatation of aorta in BAVs was the ascending aorta dilatation, root dilation was the second, and the least common was the root dilatation together with the ascending aorta [44, 48, 51]. Aortic aneurysms in BAVs commonly involve aortic root, ascending aorta, and aortic arch [42].

The relationship between the aortic valve structure and dilatation has been investigated in several studies. It was reported that RL BAV phenotype was usually associated with aortic root and/or sinus Valsalva and/or proximal aortic dilatation [28, 29, 44, 49, 52, 53, 54, 55]. RN BAV phenotype was more commonly associated with ascending aorta dilatation and LN BAV phenotypes with aortic root dilatation [29, 56]. In addition, the RN BAV phenotype was associated with a more rapid growth of the ascending aorta [43]. On the contrary, a relationship between the RL BAV phenotypes and increased risk of rapid aortic dilatation in BAV patients has been reported [57]. Clinical variation of the BAV patients may be related to different etiological entities of cusp phenotypes. Recently preclinical studies have shown that RN and RL cusps’ fusion have different pathogenesis [58, 59]. In contrast to these studies, only minor differences in aortic shape can be demonstrated in different BAV phenotypes. Aortic dilatation was primarily caused by intrinsic mechanisms of the aortic wall regardless of valve type [48].

4.4. Hemodynamic effect

Flow abnormalities, related to turbulent and helical flow patterns, as a result of the asymmetric movement of valve leaflets, may be a major contributor to aortic dilation in BAV. Even normally functioning BAVs may have abnormal transvalvular flow patterns, resulting in regional increases in wall shear stress [60, 61]. The asymmetric opening of even “clinically normal” BAV has been demonstrated. The orifice of the open BAV has been shown to be irregular and dome shaped due to the restricted motility of conjoined leaflets. This asymmetric and morphologically stenotic orifice leads to a nonaxial, turbulent transvalvular flow jet, which propagates eccentrically toward the wall of ascending aorta [61]. Restricted systolic conjoint cusp motion may cause flow deflection even if the BAV is normofunctional on echocardiographic evaluation. Systolic flow deflection toward the right, affecting the right anterolateral-ascending wall, has been demonstrated by magnetic resonance imaging (MRI) [62]. Abnormal cusp motions of BAV, including folding or wrinkling of the valve tissue and increased cusp doming during the cardiac cycle, may result in altered flow characteristics even when the cusps are not stenotic [63].

MRI studies have shown that RL BAV phenotype is associated with rightward flow deviation (flow jet directed toward the right anterior aortic wall, which is then propagated in a right-handed helical direction) and dilatation of tubular portion of the ascending aorta. Right anteriorly oriented flow jet may also result in larger aortic root dimensions and asymmetric dilatation of midascending tract [53]. However, RN BAV phenotype has been linked to the leftward deviation (flow jet directed toward left posterior aortic wall) and diffuse dilatation of the ascending aorta extending to the arch [64, 65]. The RN BAV phenotypes have shown more severe hemodynamic flow abnormalities than the RL BAV phenotypes [65].

The increase in regional wall shear stress may explain the RL BAV phenotype with dilatation of the aortic root and asymmetric dilatation of the tubular ascending aorta. Conversely, a RN BAV phenotype may result in a flow toward the posterior aorta, with increased wall shear stress at the right posterior aspect of the aorta leading to dilatation of the aortic arch [39].

4.5. Aortic regurgitation and stenosis

BAV disease is strongly associated with different degrees of stenosis, regurgitation, and mixed presentations. Although most of the neonates and infants remain asymptomatic, dysfunction may present in older ages. Valve interventions may be necessary in a minority, mainly early in life, typically for aortic stenosis (AS) [66]. The progression of stenosis is probably similar to that of TAV stenosis but it becomes manifested at least 5–10 years earlier in patients with BAV [67]. AS and aortic regurgitation (AR) are equally found in TAVs and BAVs with normal aortic dimensions. If the aorta is dilated, AS is predominantly associated with BAV, whereas AR is with TAV [48].

Aortic aneurysms associated with AS have been considered to be poststenotic dilatation because of the chronic impact of the high-flow velocity turbulent transvalvular jet on the aortic wall. Aortic stenosis in BAVs may present a significant additional risk for patients with aneurysm [68]. However, not the severity of AS, but the degree of ascending aorta dilation and the presence of moderate or more AR is associated with higher aortic root and ascending aortic diameter z scores [43]. Moderate–severe AR is generally associated with larger sinus Valsalva diameters compared with normally functioning aortic valve and AS. On the other hand, moderate–severe AS is associated with a larger ascending aortic diameter compared with the normally functioning aortic valve without AR [55]. It is very confusing whether the AR causes aortic root dilatation or if the visa versa is true, so careful follow-up of these patients is important to understand which presents earlier. The root aneurysm and AR with BAV has been linked more often to a genetic/aortopathy cause, which occurs earlier in life, independent of hemodynamic factors [44]. In young adults, it has been shown that RN BAV pattern is more commonly associated with moderate or severe AS and moderate or more AR when compared with other BAV phenotypes. In addition, RN BAV phenotype is associated with progressive valve dysfunction and is strongly predictive of valve intervention when compared with RL BAV phenotype [39, 66]. Similarly, AS has been revealed to be more common in RN BAV phenotype, whereas AR is most commonly encountered in the patients with NL BAV and RL BAV phenotypes [45, 56, 69]. Consequently, despite a variety of study results, it can be concluded that RN or RL BAV phenotypes may show progression and AS or AR may accompany with both valve morphologies.

5. Diagnosis

Most patients with BAV are unaware of the diagnosis until elderly because the symptoms and physical findings are usually absent for many years. Unless echocardiography is requested for other indications, the diagnosis is usually made at the time of an adverse cardiovascular outcome.

The systolic ejection murmur of the aortic stenosis, auscultated on the left side of the sternum, and the diastolic murmur of the aortic regurgitation, heard mainly on the apex, are highly valuable in the diagnosis. In the current area, transthoracic echocardiogram usually confirms the diagnosis of BAV disease. For the confirmation, the valve must be visualized in systole and diastole in the short axis view. The valve openings are fish-mouth shaped. Diastolic images can be misleading because the cusp fusion in the larger leaflet of a bicuspid valve may simulate a tri-leaflet valve in the closed position. It may be more difficult to make the diagnosis if there is an incomplete fusion between the cusps. The valve closure is usually eccentric and the leaflets show doming in the long axis views.

It may be difficult to make the diagnosis in the obese patients due to the nonqualified, blurred vision. In such cases, the diagnosis can be established by means of transoesaphagial echocardiography (TEE) or cardiac MRI or computerized tomography (CT) imaging.

6. Clinical course

The clinical course of BAV patients is highly non-predictable. The factors determining the prognosis are older age, RN or RL BAV phenotype, flow dynamics (right-handed flow), male gender, elevated systolic blood pressure, smoking, presence of valvular and ventricular dysfunctions, aortic dilatation, endocarditis, high total cholesterol levels, valve degeneration score, and genetic predisposition [45, 69]. Aneurysm formation, aortic dissection, severe valvular dysfunction, and endocarditis are the most important causes of morbidity and mortality of BAV disease. AR is the most common complication in younger patients, more common in males, whereas AS is more common in elderly and females [45, 55]. In addition, RN BAV phenotype is strongly predictive of valve intervention when compared with RL BAV phenotype. RN BAV phenotype has a fourfold risk of time-related valve intervention compared with RL BAV phenotype during childhood [39, 66].

Some BAV cases may present with severe stenosis or regurgitation especially in infants or children. Children who present with AS in infancy have more severe disease and poor outcomes. Fortunately, balloon valvuloplasty is the successful treatment of choice for severe AS in this age group because of very little calcification [70].

With respect to the BAV manifestations, it is estimated that only 1 in 50 children would have a clinically significant valve disease by adolescence. The majorities of BAV patients have relatively normal valve function and remain undiagnosed until 40 years of age, when stenosis develops because of leaflet calcification. In total, 53% of the BAV patients with isolated AS undergo valve replacement [65, 70, 71]. In the elderly population, AS is the most common presentation which causes 75% of patients to undergo surgery, while AR was the reason for intervention in only 13–16% of BAV patients [45, 72]. Asymptomatic adults without significant valve dysfunction enjoy excellent long-term survival with a 10- and 20-year survival rate of 97 and 90%, respectively, identical to the expected survival of the population matched for age and sex [73]. Mean follow-up of 15 years showed a 6.7% death ratio, 1.4% of which were related with the aortic valve endocarditis, 0.47% with AS, and 0.47% with AR. In total, 18.3% of these patients underwent aortic valve surgery, most of which were due to severe AS [73]. The 10-year survival rate of the asymptomatic young adults with BAV was found to be 96%. Aortic valve and ascending aorta surgery were performed in 29% of these patients [46]. On the other hand, patients with BAV-AR and root aneurysm have shown a higher risk of aortic dissection and rupture [74].

Aortic dissection occurs 9 times more often and at an average of 1 decade earlier among patients with BAV than those with TAV [63]. The patients with BAV and aortic aneurysm >4.5 cm have been found eight times more likely to undergo an aortic dissection [75]. The patients with BAV-AR have a tenfold higher risk of post-AVR aortic dissection than the patients with BAV-AS [76]. The aortic dissection rate in BAVs has been found to be 0.77% and the frequency of aortic dissection is 0.1% per patient’s year of follow-up [45].

The aortic diameter at the baseline is also an important predictor of aortic dilatation. In children under 18 years old, ascending aorta z score has been shown to progress with time and an initial z score > 2 with the presence of AS has been accepted as a clinical marker for higher z scores in early adulthood [48]. The z scores of 4 or above, present in 13% of the patients under 18 years old, have been considered to reveal significant aortic dilation which predicts the subsequent aneurysm development [75] Relevantly, it has been shown that an aortic diameter of 4 cm or more at the baseline evaluation independently predicts the subsequent development of aneurysm. The incidence of aortic dissection in these patients during 16 years of follow-up was 3.1%, significantly higher than the general population [75]. Dissection rates in the patients with the aortic diameters of above 3.5, 4.5, and 5.5 cm are 8.5, 57.1, and 10%, respectively [77]. The aortic size larger than 4.5 cm or aortic cross-sectional area/height > 8–10 should be considered for concurrent aortic valve and ascending aorta surgery [78, 79].

BAV types can predict the progression of aortic valve dysfunction or the development of aortic aneurysms [80]. The presence of a raphe has been associated with a higher prevalence of significant AS and AR, which increase the need for surgery. Despite the higher mortality in patients with BAV and raphe, raphe is not independently associated with increased all-cause mortality.

7. Treatment strategies

7.1. Medical treatment

Beta-adrenergic blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers are the antihypertensive agents of choice. Beta-adrenergic blockers have the theoretical advantage of reducing aortic wall shear stress, whereas angiotensin receptor blockers have been shown to reduce the rate of aortic growth in patients with Marfan’s syndrome [24]. The studies about the various treatment modalities are continuing vigorously.

7.2. Intervention

During childhood, insertion of a prosthetic valve is suboptimal because of the continuing growth of the child. Fortunately, at this stage, the aortic valve is usually not calcified and valvuloplasty can successfully disrupt the commissural fusion and relieve obstruction. Valvuloplasty is the interventional strategy of choice in children and in some young adults with BAV and AS [70].

7.3. Surgical treatment

Patients who have an aortic root or ascending aorta with a diameter of 45–50 mm may be considered for surgery only if they have high-risk features such as a family history of aortic dissection, rupture, or sudden death, and an aortic growth rate of more than 5 mm per year and if there is no need for valvular surgery [81]. Currently, aortic root surgery is not usually performed if the root measurement is <45 mm, or ratio of maximum ascending aorta area to body-height ratio is <10 cm2/m [82]. Guidelines recommend ascending aortic replacement in patients with BAV if the ascending aortic diameter is ≥50 mm. Concomitant aortic surgery is suggested if the diameter exceeds 45 mm [83]. Nonetheless, some authors have recommended ascending aorta surgery at 40 mm along with concomitant aortic valve regurgitataion (AVR), if the operation risk is low and expected survival is 1 decade or longer. Moreover, many surgeons consider reinforcing or replacing the ascending aorta at the time of valve surgery if there is an increased risk of further root dilation [84, 85, 86]. Aortic root dilatation may progress after AVR in the patients with pure AR. BAV patients with AR and root dilatation of 40–50 mm (root phenotype) are associated with significant risk (34%) of post-AVR aortic events. Therefore, simultaneous aortic root surgery is suggested in the patients with BAV-AR and aortic root diameter > 40 mm during their initial AVR procedure [86]. Some of the surgeons recommend aortic repair at the time of BAV surgery if either the aortic diameter exceeds approximately 45 mm or the aortic cross-sectional area/height is above 8–9 cm2/m or z score is above 7 [82].

8. Conclusion

BAV is a very common, congenital, phenotypically variable, and genetically heterogeneous heart disease. It has a complex developmental process and distinct morphological phenotypes. The clinical course is highly non-predictable. Children with BAV are mostly asymptomatic. However, the cases with severe AS may be encountered early in life and need intervention. Aortic dilatation and valvular dysfunction may begin in infancy and make progress with age. The factors determining the prognosis of BAV disease are older age, RN or RL BAV phenotype, flow dynamics (right-handed flow), male gender, elevated systolic blood pressure, smoking, presence of valvular and ventricular dysfunctions, aortic dilatation, endocarditis, high total cholesterol levels, valve degeneration score, and genetic predisposition. Surgery is recommended for the patients with severe valvular dysfunction (AS, AR), aortic dilatation, or aneurysm.

© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Ayşe Inci Yıldırım and Aysu Türkmen Karaağaç (October 3rd 2018). Bicuspid Aortic Valve, Structural Insufficiency Anomalies in Cardiac Valves, Kaan Kirali, IntechOpen, DOI: 10.5772/intechopen.76643. Available from:

chapter statistics

171total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Contemporary Surgical Options for the Aortic Root

By Ziv Beckerman and Edward P. Chen

Related Book

First chapter

Introductory Chapter: Last Crossroad

By Kaan Kırali

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us